14
Participants
Start Date
October 31, 2016
Primary Completion Date
October 2, 2019
Study Completion Date
MS Clinical Trials Group - UBC, Vancouver
Teva Pharmaceuticals USA
INDUSTRY
University of British Columbia
OTHER